Cargando…

Interaction between DRD2 and AKT1 genetic variations on risk of psychosis in cannabis users: a case–control study

Detalles Bibliográficos
Autores principales:	Colizzi, Marco, Iyegbe, Conrad, Powell, John, Blasi, Giuseppe, Bertolino, Alessandro, Murray, Robin M, Di Forti, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849451/ https://www.ncbi.nlm.nih.gov/pubmed/27336035 http://dx.doi.org/10.1038/npjschz.2015.25

Ejemplares similares

Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
por: Hindocha, Chandni, et al.
Publicado: (2020)

S24. IS IT FEASIBLE TO PREDICT LONG-TERM METABOLIC OUTCOMES IN PSYCHOSIS USING BIOLOGICAL PROFILING AT BASELINE?
por: Iyegbe, Conrad, et al.
Publicado: (2018)

O4.5. INVESTIGATING GENETIC PROFILES ASSOCIATED WITH ‘REAL WORLD’ CLINICAL OUTCOMES IN PSYCHOSIS: A RETROSPECTIVE COHORT STUDY
por: Francis, Emma, et al.
Publicado: (2018)

Familial risk and childhood adversity interplay in the onset of psychosis
por: Trotta, Antonella, et al.
Publicado: (2015)

Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis
por: Bortoletto, Riccardo, et al.
Publicado: (2022)

T104. ASSESSING THE UTILITY OF COPULA FUNCTIONS FOR RISK PREDICTION OF PSYCHOSIS
por: Zhang, Landan, et al.
Publicado: (2018)

Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
por: Colizzi, Marco, et al.
Publicado: (2020)

O12.4. SOME OF THE INDIVIDUAL DIFFERENCES IN RISK TO DEVELOP PSYCHOSIS AMONG CANNABIS USERS CAN BE EXPLAINED BY WHERE THEY LIVE AND BY THEIR AGE AT FIRST USE
por: Di Forti, Marta, et al.
Publicado: (2018)

S126. THE RELATION OF THE PSYCHOSIS CONTINUUM WITH SCHIZOPHRENIA POLYGENIC RISK SCORE AND CANNABIS USE
por: Quattrone, Diego, et al.
Publicado: (2020)

Differential gene expression analysis in blood of first episode psychosis patients
por: Leirer, Daniel J., et al.
Publicado: (2019)

DRD2/CHRNA5 Interaction on Prefrontal Biology and Physiology during Working Memory
por: Di Giorgio, Annabella, et al.
Publicado: (2014)

Schizophrenia and Influenza at the Centenary of the 1918-1919 Spanish Influenza Pandemic: Mechanisms of Psychosis Risk
por: Kępińska, Adrianna P., et al.
Publicado: (2020)

Prefronto-striatal physiology is associated with schizotypy and is modulated by a functional variant of DRD2
por: Taurisano, Paolo, et al.
Publicado: (2014)

T197. A DRD2 CO-EXPRESSION GENE SET ENRICHED FOR SCHIZOPHRENIA RISK GENES IS CHARACTERIZED BY A COMMON TRANSCRIPTIONAL REGULATION INVOLVING NURR1 TRANSCRIPTION FACTOR
por: Torretta, Silvia, et al.
Publicado: (2018)

Poor medication adherence and risk of relapse associated with continued cannabis use in patients with first-episode psychosis: a prospective analysis
por: Schoeler, Tabea, et al.
Publicado: (2017)

Decreased respiratory symptoms in cannabis users who vaporize
por: Earleywine, Mitch, et al.
Publicado: (2007)

Cannabis labelling is associated with genetic variation in terpene synthase genes
por: Watts, Sophie, et al.
Publicado: (2021)

State Variation in U.S. Medical Cannabis Limits, Restrictions, and Therapeutic Cannabis Dosing
por: Steuart, Shelby R.
Publicado: (2023)

Role of Environmental Confounding in the Association between FKBP5 and First-Episode Psychosis
por: Ajnakina, Olesya, et al.
Publicado: (2014)

Expanding the Spectrum of Dopa-Responsive Dystonia (DRD) and Proposal for New Definition: DRD, DRD-plus, and DRD Look-alike
por: Lee, Woong-Woo, et al.
Publicado: (2018)

Smoked Cannabis Effects in Cannabis Users at Clinical High-Risk for Psychosis: A Further Investigation of Cognition and Reward
por: Madden, Sean P., et al.
Publicado: (2022)

Cannabis and psychosis: Neurobiology
por: Shrivastava, Amresh, et al.
Publicado: (2014)

Cannabis Induced Psychosis
por: Bramness, J.
Publicado: (2022)

Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis
por: Sami, Musa, et al.
Publicado: (2020)

Associations Between Cannabis Use, Polygenic Liability for Schizophrenia, and Cannabis-related Experiences in a Sample of Cannabis Users
por: Johnson, Emma C, et al.
Publicado: (2022)

Does environmental confounding mask pleiotropic effects of a multiple sclerosis susceptibility variant on vitamin D in psychosis?
por: Iyegbe, Conrad O, et al.
Publicado: (2015)

Characteristics of Cannabis-Only and Other Drug Users Who Visit the Emergency Department
por: Woodruff, Susan I., et al.
Publicado: (2016)

Acute effects of cocaine and cannabis on reversal learning as a function of COMT and DRD2 genotype
por: Spronk, Desirée B., et al.
Publicado: (2015)

A polygenic score indexing a DRD2-related co-expression network is associated with striatal dopamine function
por: D’Ambrosio, Enrico, et al.
Publicado: (2022)

Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example
por: Di Gennaro, Gianfranco, et al.
Publicado: (2023)

T26. PERINATAL STRESS AND PSYCHOSIS: RESULTS FROM THE BOLOGNA FIRST EPISODE PSYCHOSIS (BO-FEP) STUDY
por: Tarricone, Ilaria, et al.
Publicado: (2018)

Linkage and association of variants in the dopamine receptor 2 gene (DRD2) with polycystic ovary syndrome
por: Amin, Mutaz, et al.
Publicado: (2023)

T189. PEPTIDE SHARING BETWEEN SCHIZOPHRENIA-RELATED PROTEINS AND THE INFLUENZA A VIRUS MAY OFFER A WINDOW INTO THE IMMUNE AETIOLOGY OF PSYCHOTIC DISORDERS
por: Kepinska, Adrianna, et al.
Publicado: (2018)

Pattern of predictive features of continued cannabis use in patients with recent-onset psychosis and clinical high-risk for psychosis
por: Penzel, Nora, et al.
Publicado: (2022)

Impact of cannabis use and cannabis cessation on inflammation in patients with psychosis
por: Romeo, B., et al.
Publicado: (2023)

Associations between the schizophrenia susceptibility gene ZNF804A and clinical outcomes in psychosis
por: Wickramasinghe, A, et al.
Publicado: (2015)

Risk factors for cannabis use disorders and cannabis psychosis in Japan: Second report of a survey on cannabis‐related health problems among community cannabis users using social networking services
por: Masataka, Yuji, et al.
Publicado: (2022)

S224. DELTA-9-TETRAHYDROCANNABINOL CHALLENGE IN CANNABIS USERS AND NON-USERS DIFFERENTIALLY AFFECTS BRAIN FUNCTION AND BEHAVIOR: AN FMRI STUDY OF DEVELOPMENT OF TOLERANCE
por: Colizzi, Marco, et al.
Publicado: (2018)

Cannabis use by women during pregnancy does not influence infant DNA methylation of the dopamine receptor DRD4
por: Fransquet, Peter D., et al.
Publicado: (2017)

A brain imaging study of dopamine receptor D(2) availability in cannabis dependent users after recovery from cannabis-induced psychosis
por: Weinstein, Aviv M.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p7p7b9d9pbomshp3d8jqoccnf6